Developing a therapeutic anti-dendritic cell antibody to prevent graft versus host disease
Hart, Derek, Seldon, Therese, Jones, Martina, Sheng, Yonghua, Palkova, Anna, Cullup, Hannah, Munro, Trent, Sinfield, Laura, Rice, Alison M., Wilson, John, Gray, Peter, Barnard, Ross, Mahler, Stephen, & Munster, David J. (2009) Developing a therapeutic anti-dendritic cell antibody to prevent graft versus host disease. In 51st Annual Meeting of the American Society of Hematology, 5-8 December 2009, New Orleans, USA.
Host and donor dendritic cells (DC) stimulate alloreactive donor T lymphocytes, and initiate GVHD. We have shown that polyclonal antibody to the DC surface activation marker human CD83 (anti hCD83), which depletes activated DC, can prevent human DC and T cell induced lethal xenogeneic GVHD in SCID mice without impairing T cell mediated anti-leukaemic and anti-viral (CMV and influenza) immunity (J Exp Med 2009; 206: 387). Therefore, we made and tested a polyclonal anti mouse CD83 (RAM83) antibody in murine HSCT models and developed a human mAb against hCD83 as a potential new therapeutic immunosuppressive agent.
Impact and interest:
Citation counts are sourced monthly from and citation databases.
These databases contain citations from different subsets of available publications and different time periods and thus the citation count from each is usually different. Some works are not in either database and no count is displayed. Scopus includes citations from articles published in 1996 onwards, and Web of Science® generally from 1980 onwards.
Citations counts from theindexing service can be viewed at the linked Google Scholar™ search.
|Item Type:||Conference Item (Other)|
|Divisions:||Current > QUT Faculties and Divisions > Faculty of Health|
|Deposited On:||30 Mar 2015 06:04|
|Last Modified:||30 Mar 2015 06:05|
Repository Staff Only: item control page